DK1820792T3 - Fremgangsmåde til fremstilling af adamantanaminer - Google Patents
Fremgangsmåde til fremstilling af adamantanaminerInfo
- Publication number
- DK1820792T3 DK1820792T3 DK06003477.4T DK06003477T DK1820792T3 DK 1820792 T3 DK1820792 T3 DK 1820792T3 DK 06003477 T DK06003477 T DK 06003477T DK 1820792 T3 DK1820792 T3 DK 1820792T3
- Authority
- DK
- Denmark
- Prior art keywords
- formula
- treatment
- adamantanamine
- disease
- methyl
- Prior art date
Links
- DKNWSYNQZKUICI-UHFFFAOYSA-N amantadine Chemical class C1C(C2)CC3CC2CC1(N)C3 DKNWSYNQZKUICI-UHFFFAOYSA-N 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 3
- HOKKHZGPKSLGJE-GSVOUGTGSA-N N-Methyl-D-aspartic acid Chemical compound CN[C@@H](C(O)=O)CC(O)=O HOKKHZGPKSLGJE-GSVOUGTGSA-N 0.000 abstract 2
- 229960003805 amantadine Drugs 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 abstract 2
- 208000024827 Alzheimer disease Diseases 0.000 abstract 1
- 208000018737 Parkinson disease Diseases 0.000 abstract 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Natural products NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 abstract 1
- 238000010306 acid treatment Methods 0.000 abstract 1
- 229960001280 amantadine hydrochloride Drugs 0.000 abstract 1
- WOLHOYHSEKDWQH-UHFFFAOYSA-N amantadine hydrochloride Chemical compound [Cl-].C1C(C2)CC3CC2CC1([NH3+])C3 WOLHOYHSEKDWQH-UHFFFAOYSA-N 0.000 abstract 1
- 230000000840 anti-viral effect Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 229960000967 memantine hydrochloride Drugs 0.000 abstract 1
- LDDHMLJTFXJGPI-UHFFFAOYSA-N memantine hydrochloride Chemical compound Cl.C1C(C2)CC3(C)CC1(C)CC2(N)C3 LDDHMLJTFXJGPI-UHFFFAOYSA-N 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 239000002464 receptor antagonist Substances 0.000 abstract 1
- 229940044551 receptor antagonist Drugs 0.000 abstract 1
- 230000036967 uncompetitive effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
- C07C233/04—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C233/06—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
- C07C209/62—Preparation of compounds containing amino groups bound to a carbon skeleton by cleaving carbon-to-nitrogen, sulfur-to-nitrogen, or phosphorus-to-nitrogen bonds, e.g. hydrolysis of amides, N-dealkylation of amines or quaternary ammonium compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C335/30—Isothioureas
- C07C335/32—Isothioureas having sulfur atoms of isothiourea groups bound to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/56—Ring systems containing bridged rings
- C07C2603/58—Ring systems containing bridged rings containing three rings
- C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
- C07C2603/74—Adamantanes
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hospice & Palliative Care (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Psychiatry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06003477A EP1820792B1 (en) | 2006-02-21 | 2006-02-21 | Process for the preparation of adamantanamines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1820792T3 true DK1820792T3 (da) | 2012-04-10 |
Family
ID=36754153
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK06003477.4T DK1820792T3 (da) | 2006-02-21 | 2006-02-21 | Fremgangsmåde til fremstilling af adamantanaminer |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20090082596A1 (https=) |
| EP (1) | EP1820792B1 (https=) |
| JP (1) | JP5235683B2 (https=) |
| CN (1) | CN101389594B (https=) |
| AT (1) | ATE541827T1 (https=) |
| AU (1) | AU2007218140B2 (https=) |
| CA (1) | CA2640127C (https=) |
| DK (1) | DK1820792T3 (https=) |
| ES (1) | ES2379181T3 (https=) |
| PL (1) | PL1820792T3 (https=) |
| PT (1) | PT1820792E (https=) |
| SI (1) | SI1820792T1 (https=) |
| WO (1) | WO2007096124A1 (https=) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1908748A1 (en) | 2006-10-05 | 2008-04-09 | Krka | Process for the preparation of memantine and its hydrochloric acid salt form |
| WO2010007351A1 (en) * | 2008-07-14 | 2010-01-21 | Cipla Limited | Process for the preparation of memantine and its salts and intermediate for use therein |
| CN101560157B (zh) * | 2009-06-02 | 2013-09-18 | 王彦明 | 盐酸金刚烷胺生产工艺及其专用设备 |
| CN102070463A (zh) * | 2009-06-11 | 2011-05-25 | 辽宁利锋科技开发有限公司 | 具有金刚烷结构药物美金刚胺及其衍生物和类似物抗肿瘤新适应症的应用 |
| JP5749260B2 (ja) * | 2009-06-29 | 2015-07-15 | メルツ・ファルマ・ゲーエムベーハー・ウント・コ・カーゲーアーアー | ネラメキサンの製造方法 |
| HRP20130485T1 (en) * | 2009-06-29 | 2013-06-30 | Merz Pharma Gmbh & Co. Kgaa | Method of preparing 1-amino-1,3,3,5,5-pentamethylcyclohexane |
| HRP20130486T1 (en) * | 2009-06-29 | 2013-06-30 | Merz Pharma Gmbh & Co. Kgaa | Method of preparing neramexane |
| EP2448911A1 (en) * | 2009-06-29 | 2012-05-09 | Merz Pharma GmbH & Co. KGaA | Method of preparing 1-chloroacetamido-1,3,3,5,5-pentamethylcyclohexane |
| CN101993377A (zh) * | 2009-08-07 | 2011-03-30 | 出光兴产株式会社 | 具有金刚烷骨架的胺类和季铵盐的制造方法 |
| CN104936942A (zh) * | 2013-01-23 | 2015-09-23 | 三菱瓦斯化学株式会社 | 美金刚胺的制造工艺 |
| CN103483205B (zh) * | 2013-10-12 | 2015-02-04 | 合肥久诺医药科技有限公司 | 一种高纯度盐酸美金刚的制备方法 |
| CN103524353B (zh) * | 2013-10-12 | 2015-03-25 | 合肥久诺医药科技有限公司 | 一种高纯度盐酸美金刚的制备方法 |
| CN104693039B (zh) * | 2015-01-06 | 2016-11-16 | 中山大学 | 一种金刚烷胺类衍生物及其制备方法和应用 |
| CN105399636A (zh) * | 2015-12-18 | 2016-03-16 | 天津民祥生物医药股份有限公司 | 一种利用盐酸金刚烷胺制备金刚烷胺游离胺的工艺 |
| CN117843492A (zh) * | 2023-12-04 | 2024-04-09 | 四川众邦新材料股份有限公司 | 金刚烷胺生产中的产物分离提取方法 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3391142A (en) | 1966-02-09 | 1968-07-02 | Lilly Co Eli | Adamantyl secondary amines |
| ES413944A1 (es) * | 1972-04-20 | 1976-06-01 | Merz & Co | Procedimiento para la preparacion de compuestos de adamen- tano trisustituidos en las posiciones 1,3,5. |
| DE2318461A1 (de) | 1973-04-12 | 1974-10-31 | Merz & Co | Verfahren zur herstellung von 1,3,5trisubstituierten adamanta-verbindungen |
| SU805609A1 (ru) * | 1979-10-12 | 1981-09-30 | Предприятие П/Я В-2343 | S-(1-адамантилкарбпмоилметил) изотиуроний хлорид,обладающий антивирусной активностью |
| ES2059602T3 (es) | 1989-04-14 | 1994-11-16 | Merz & Co Gmbh & Co | Uso de derivados de adamantano para la prevencion y tratamiento de isquemia cerebral. |
| US5948820A (en) * | 1994-08-22 | 1999-09-07 | Yoshitomi Pharmaceutical Industries, Ltd. | Benzene compound and pharmaceutical use thereof |
| CZ288445B6 (en) | 1996-06-20 | 2001-06-13 | Lachema Np | Process for preparing hydrochloride of 5-amino-1,3-dimethyltricyclo(3,3,1,1 3,7 )decane |
| GB0001093D0 (en) | 2000-01-19 | 2000-03-08 | F2 Chemicals Ltd | Selective nitrogen functionalisation of organic compounds |
| GB0018272D0 (en) * | 2000-07-25 | 2000-09-13 | Vernalis Research Limited | Chemical compounds IV |
| JP4118555B2 (ja) * | 2001-12-13 | 2008-07-16 | 株式会社トクヤマ | Ｎ−（アダマンチル）アミド化合物の製造方法 |
| RU2246482C2 (ru) | 2002-12-25 | 2005-02-20 | ООО "Циклан" | Способ получения гидрохлорида 1-амино-3,5-диметиладамантана |
| CN1240668C (zh) | 2003-09-10 | 2006-02-08 | 上海医药工业研究院 | 一种新的盐酸美金刚制备方法 |
| WO2005062724A2 (en) * | 2003-12-31 | 2005-07-14 | Sun Pharmaceutical Industries Limited | Novel process for the preparation of aminoadamantane derivatives |
| EP1708707A1 (en) * | 2004-01-22 | 2006-10-11 | Neurosearch A/S | Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and an n-methyl-d-aspartate (nmda) receptors antagonist |
| US7456224B2 (en) * | 2004-04-05 | 2008-11-25 | Forest Laboratories Holdings, Ltd. | Method for treating autism |
| EP1879849A1 (en) * | 2005-05-11 | 2008-01-23 | Dr. Reddy's Laboratories, Inc. | Process for preparing memantine |
-
2006
- 2006-02-21 AT AT06003477T patent/ATE541827T1/de active
- 2006-02-21 ES ES06003477T patent/ES2379181T3/es not_active Expired - Lifetime
- 2006-02-21 EP EP06003477A patent/EP1820792B1/en not_active Expired - Lifetime
- 2006-02-21 DK DK06003477.4T patent/DK1820792T3/da active
- 2006-02-21 SI SI200631279T patent/SI1820792T1/sl unknown
- 2006-02-21 PT PT06003477T patent/PT1820792E/pt unknown
- 2006-02-21 PL PL06003477T patent/PL1820792T3/pl unknown
-
2007
- 2007-02-20 CA CA2640127A patent/CA2640127C/en not_active Expired - Fee Related
- 2007-02-20 CN CN2007800060848A patent/CN101389594B/zh not_active Expired - Fee Related
- 2007-02-20 AU AU2007218140A patent/AU2007218140B2/en not_active Ceased
- 2007-02-20 WO PCT/EP2007/001440 patent/WO2007096124A1/en not_active Ceased
- 2007-02-20 JP JP2008555684A patent/JP5235683B2/ja active Active
- 2007-02-20 US US12/224,147 patent/US20090082596A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CN101389594A (zh) | 2009-03-18 |
| EP1820792A1 (en) | 2007-08-22 |
| ES2379181T3 (es) | 2012-04-23 |
| AU2007218140B2 (en) | 2010-08-19 |
| AU2007218140A1 (en) | 2007-08-30 |
| JP5235683B2 (ja) | 2013-07-10 |
| EP1820792B1 (en) | 2012-01-18 |
| CA2640127A1 (en) | 2007-08-30 |
| WO2007096124A1 (en) | 2007-08-30 |
| CA2640127C (en) | 2015-08-11 |
| US20090082596A1 (en) | 2009-03-26 |
| PT1820792E (pt) | 2012-04-10 |
| CN101389594B (zh) | 2013-06-12 |
| ATE541827T1 (de) | 2012-02-15 |
| PL1820792T3 (pl) | 2012-06-29 |
| JP2009527517A (ja) | 2009-07-30 |
| SI1820792T1 (sl) | 2012-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1820792T3 (da) | Fremgangsmåde til fremstilling af adamantanaminer | |
| TW200833682A (en) | Pharmaceutical compounds | |
| BRPI0816911A8 (pt) | Processo para preparação de 4-aminobut-2-enolidas | |
| MX2010007587A (es) | Compuestos que comprenden un grupo ciclobutoxi. | |
| BR112012032244A2 (pt) | processo para preparar derivados de antranilamida com tetrazole-substituído e polimorfos cristalinos novos e derivados destes | |
| BRPI0813284A8 (pt) | Processo para a preparação de um composto da fórmula (i) e composto | |
| ECSP066373A (es) | Forma cristalina beta de clorhidrato de ivabradina, su procedimiento de preparación y composiciones farmacéuticas que la contienen | |
| UA102817C2 (ru) | Способ синтеза агомелатина | |
| UA100367C2 (uk) | Спосіб одержання мемантину і його гідрохлориду | |
| BRPI0905147A8 (pt) | processo para síntese de ivabradina e seus sais de adição com um ácido farmaceuticamente aceitável | |
| DK1893587T3 (da) | Fremgangsmåde til fremstilling af dihydroquinazoliner | |
| UA97806C2 (ru) | Бензиламины, способ их получения и их применения в качестве противовоспалительных средств | |
| MY151017A (en) | 5-[(3,3,3-trifluoro-2-hydroxy-1-arylpropyl)amino]-1h-quinolin-2-ones, a process for their production and their use as anti-inflammatory agents | |
| DE602006009619D1 (de) | Verfahren zur herstellung von 1-amino-3,5-dimethyladamantan-hydrochlorid | |
| WO2009135598A8 (en) | Process for preparing substituted biphenylanilides | |
| ZA201003751B (en) | Process for the synthesis of propargylated aminoindan derivatives | |
| UA106195C2 (ru) | Способ синтеза агомелатина | |
| BRPI0517390A (pt) | processo para a preparação de derivados de [1,4,5]-oxadiazepina | |
| IL200323A0 (en) | Synthesis of glyt-1 inhibitors | |
| BRPI0922787A2 (pt) | Formas polimórficas de um derivado da azabiciclo-trifluorometil benzamida | |
| EA200870038A1 (ru) | Способ получения аминов | |
| IL183805A0 (en) | Process for preparing substituted thiophenesulfonyl isocyanates | |
| BRPI0702817A (pt) | compostos de naftaleno, processo para sua preparação e composições farmacêuticas que contêm esses compostos | |
| WO2008099418A3 (en) | An improved process for preparing bupropion hydrochloride | |
| BRPI0409012A (pt) | processos para preparação de um produto reacional, de uma composição farmacêutica, de uma composição agroquìmica, de uma composição de limpeza, de uma composição de tinta e de um refrigerante ou lubrificante |